7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Measuring Thousands of Single-Vesicle Leakage Events Reveals the Mode of Action of Antimicrobial Peptides

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Host defense or antimicrobial peptides hold promise for providing new pipelines of effective antimicrobial agents. Their activity quantified against model phospholipid membranes is fundamental to a detailed understanding of their structure–activity relationships. However, classical characterization assays often lack the ability to achieve this insight. Leveraging a highly parallelized microfluidic platform for trapping and studying thousands of giant unilamellar vesicles, we conducted quantitative long-term microscopy studies to monitor the membrane-disruptive activity of archetypal antimicrobial peptides with a high spatiotemporal resolution. We described the modes of action of these peptides via measurements of the disruption of the vesicle population under the conditions of continuous peptide dosing using a range of concentrations and related the observed modes to the molecular activity mechanisms of these peptides. The study offers an effective approach for characterizing membrane-targeting antimicrobial agents in a standardized manner and for assigning specific modes of action to the corresponding antimicrobial mechanisms.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Defensins: antimicrobial peptides of innate immunity.

          Tomas Ganz (2003)
          The production of natural antibiotic peptides has emerged as an important mechanism of innate immunity in plants and animals. Defensins are diverse members of a large family of antimicrobial peptides, contributing to the antimicrobial action of granulocytes, mucosal host defence in the small intestine and epithelial host defence in the skin and elsewhere. This review, inspired by a spate of recent studies of defensins in human diseases and animal models, focuses on the biological function of defensins.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The value of antimicrobial peptides in the age of resistance

            Accelerating growth and global expansion of antimicrobial resistance has deepened the need for discovery of novel antimicrobial agents. Antimicrobial peptides have clear advantages over conventional antibiotics which include slower emergence of resistance, broad-spectrum antibiofilm activity, and the ability to favourably modulate the host immune response. Broad bacterial susceptibility to antimicrobial peptides offers an additional tool to expand knowledge about the evolution of antimicrobial resistance. Structural and functional limitations, combined with a stricter regulatory environment, have hampered the clinical translation of antimicrobial peptides as potential therapeutic agents. Existing computational and experimental tools attempt to ease the preclinical and clinical development of antimicrobial peptides as novel therapeutics. This Review identifies the benefits, challenges, and opportunities of using antimicrobial peptides against multidrug-resistant pathogens, highlights advances in the deployment of novel promising antimicrobial peptides, and underlines the needs and priorities in designing focused development strategies taking into account the most advanced tools available.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Describing the mechanism of antimicrobial peptide action with the interfacial activity model.

              Antimicrobial peptides (AMPs) have been studied for three decades, and yet a molecular understanding of their mechanism of action is still lacking. Here we summarize current knowledge for both synthetic vesicle experiments and microbe experiments, with a focus on comparisons between the two. Microbial experiments are done at peptide to lipid ratios that are at least 4 orders of magnitude higher than vesicle-based experiments. To close the gap between the two concentration regimes, we propose an "interfacial activity model", which is based on an experimentally testable molecular image of AMP-membrane interactions. The interfacial activity model may be useful in driving engineering and design of novel AMPs.
                Bookmark

                Author and article information

                Journal
                Anal Chem
                Anal Chem
                ac
                ancham
                Analytical Chemistry
                American Chemical Society
                0003-2700
                1520-6882
                27 June 2022
                12 July 2022
                : 94
                : 27
                : 9530-9539
                Affiliations
                []Cavendish Laboratory, University of Cambridge , J.J. Thomson Avenue, Cambridge CB3 0HE, U.K.
                []National Physical Laboratory , Hampton Road, Teddington TW11 0LW, U.K.
                [§ ]London Centre for Nanotechnology, University College London , London WC1H 0AH, U.K.
                []Research Center Borstel, Leibniz Lung Center , Parkallee 10, Borstel 23845, Germany
                []Living Systems Institute, University of Exeter , Stocker Road, Exeter EX4 4QD, U.K.
                [# ]College of Engineering, Mathematics and Physical Sciences, University of Exeter , North Park Road, Exeter EX4 4QF, U.K.
                []Department of Physics, King’s College London , Strand Lane, London WC2R 2LS, U.K.
                Author notes
                Author information
                https://orcid.org/0000-0003-4568-5894
                https://orcid.org/0000-0003-3036-1168
                https://orcid.org/0000-0002-3755-6489
                https://orcid.org/0000-0002-9210-3271
                https://orcid.org/0000-0002-5982-1941
                https://orcid.org/0000-0003-4847-1154
                https://orcid.org/0000-0003-3188-5414
                Article
                10.1021/acs.analchem.1c03564
                9280716
                35760038
                95c90314-567f-4583-9049-288e21610c04
                © 2022 The Authors. Published by American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                Funding
                Funded by: Wellcome Trust, doi 10.13039/100004440;
                Award ID: 204909/Z/16/Z
                Funded by: Phospholipid Research Center, doi 10.13039/501100011748;
                Award ID: NA
                Funded by: Innovate UK, doi 10.13039/501100006041;
                Award ID: 103358
                Funded by: Trinity College, University of Cambridge, doi 10.13039/501100000727;
                Award ID: NA
                Funded by: Engineering and Physical Sciences Research Council, doi 10.13039/501100000266;
                Award ID: NA
                Funded by: Department for Business, Energy and Industrial Strategy, UK Government, doi 10.13039/100011693;
                Award ID: NA
                Funded by: H2020 European Research Council, doi 10.13039/100010663;
                Award ID: 647144
                Categories
                Article
                Custom metadata
                ac1c03564
                ac1c03564

                Analytical chemistry
                Analytical chemistry

                Comments

                Comment on this article